The FDA Foundation regularly hosts a Lab Meeting which is named for the popular graduate school lunch-time forum for gathering and sharing information. For the Evidence Accelerator, the focus is on sharing information about COVID-19 and the data needed to better understand its epidemiology, diagnosis, treatment, and prevention. The Evidence Accelerator abides by Chatham House Rules and requests attendants to keep the conversation “in the room” because more often than not, preliminary data are being shared in an informal, real-time peer review. From March 2020 to March 2021, the Evidence Accelerator has hosted 50 Therapeutics Lab Meetings and 45 Diagnostics Lab Meetings.
